| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-06 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0004 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0004 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
| mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0005 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |